Get started
Author

Kristen M. Ahlschwede

Observed names: Kristen Ahlschwede, Kristen M Ahlschwede, Kristen M. Jaruszewski
Observed institutions: University of Minnesota, National Center for Toxicological Research, United States Food and Drug Administration, Mayo Clinic, Rosalind Franklin University of Medicine and Science, University of Minnesota System, Florida Agricultural and Mechanical University
ORCID: 0000-0002-1578-8326
Observed ORCID: 0000-0002-1578-8326
OpenAlex ID: A5081889438
Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein
2011 · Kristen M. Jaruszewski, Subramanian Ramakrishnan, et al. · Nanomedicine Nanotechnology Biology and Medicine · 77
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits
2014 · Edward K. Agyare, Kristen M. Jaruszewski, et al. · Journal of Controlled Release · 71
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain
2018 · Kristen M. Ahlschwede, Geoffry L. Curran, et al. · Nanomedicine Nanotechnology Biology and Medicine · 67
Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain
2017 · Suresh Kumar Swaminathan, Kristen M Ahlschwede, et al. · Journal of Cerebral Blood Flow & Metabolism · 67
Multimodal Nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain
2013 · Kristen M. Jaruszewski, Geoffry L. Curran, et al. · Biomaterials · 64
Nanotechnology-based therapies for the prevention and treatment of Streptococcus mutans-derived dental caries
2021 · Felix Amissah, Terrick Andey, et al. · Journal of Oral Biosciences · 33
High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma
2020 · Suresh K. Swaminathan, Andrew L. Zhou, et al. · Journal of Pharmacology and Experimental Therapeutics · 22
PDF
Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium
2020 · Nidhi Sharda, Kristen M. Ahlschwede, et al. · Journal of Pharmacology and Experimental Therapeutics · 16
PDF
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin
2021 · Andrew L. Zhou, Nidhi Sharda, et al. · Journal of Alzheimer s Disease · 12
PDF
Formulation, Characterization, and the Diuretic Effects of a New Intravenous Metolazone Emulsion
2022 · Kristen M. Ahlschwede, Edward Ofori, et al. · Drug Research · 2
P1‐197: Amyloid Beta Effects on Insulin Permeability From Plasma to Brain Measured by I‐125 Insulin Spect in App/ps1 Mice
2018 · Suresh K. Swaminathan, Hoon-Ki Min, et al. · Alzheimer s & Dementia · 2
Evaluating the effect of cationic peptide K16ApoE against Staphylococcus epidermidis biofilms
2021 · Kristen M. Ahlschwede, Felix Amissah, et al. · Journal of Pharmaceutical Investigation · 1
Cryo Transmission Electron Microscopy of Three Research-Grade Liposomal Formulations of Doxorubicin
2015 · William Monroe, Angel Paredes, et al. · Microscopy and Microanalysis · 1
Works count: 13
Citation count: 435
H-index: 9
I10-index: 9
Year
Topic
Type